Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Freeslate, provider of laboratory automation solutions, has entered into a collaborative relationship with Amgen to address aggregation and particulation in protein drug products.
Subscribe to our email newsletter
The collaboration will make use of Freeslate products and services, including technology development, microscale workflows, and Freeslate’s Lab Execution and Analysis (LEA) software, which will enable gains in R&D productivity and innovation.
Freeslate’s integrated workflows are managed by its LEA software platform which creates a single, experimental environment that helps in scientific decision making.
Freeslate CEO John Senaldi said the formulation of protein therapeutics is a cause of concern for pharmaceutical companies.
"High throughput research can enable significant steps forward in both understanding and addressing the challenges of aggregation and particulation in protein drug products," Senaldi added.